Polio eradication. Efficacy of inactivated poliovirus vaccine in India - sprookjes - yvandenbroek - TriplyDB

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

http://www.wikidata.org/entity/Q28246469

about

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies Vaccines against enteric infections for the developing world Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial.The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.Polio endgame: the global introduction of inactivated polio vaccine.Polio vaccination: past, present and future.Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.Microneedle patches for vaccination in developing countries.Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers.Alternative administration routes and delivery technologies for polio vaccines.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.Immunogenicity of antigen-conjugated biodegradable polydiacetylene liposomes administered mucosally.Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.Maximising the impact of inactivated polio vaccines.Mass immunization with inactivated polio vaccine in conflict zones--Experience from Borno and Yobe States, North-Eastern Nigeria.Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants Polio endgame: the global switch from tOPV to bOPV.The risk of type 2 oral polio vaccine use in post-cessation outbreak response.Modelling Risk to US Military Populations from Stopping Blanket Mandatory Polio Vaccination.Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccine.The polio eradication endgame: Why immunization and continued surveillance is critical.Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model

P2860

Q26770541-A1C948D7-AAAA-49C3-BFD6-22D22709C8BB Q28080866-2CA22869-E5DE-4A5B-BE3C-F6740ECBED94 Q30274784-6ECE5889-878B-48E6-A69C-2B8EAB252658 Q33553771-C95EF3EC-4F03-4EFA-B205-CFC266101E87 Q35661264-C56DFF69-960F-4090-A58C-51E18EE82A9D Q35662053-5981D719-27B9-42CB-8DF5-046EFBF2D128 Q35779660-5287BFCC-C295-4C7E-BEE0-0C9D57A63D0A Q35779856-A7E21DB7-D2CA-4938-8DD5-D8ECD6F3570B Q35787331-916763F3-F900-41C5-87A7-2FF8B23EFEFA Q35885000-930ABF03-38F7-4BEE-AC65-AFEC072BB0E6 Q35965234-CC166D17-8620-48B6-920B-B5BA146D1C24 Q36069274-87F935DC-965F-418C-B6B9-970BDC7ADB9A Q38322526-CA1DB7B1-B692-432F-8731-C40856F812B2 Q38396773-775B77A8-B5EC-43AD-8712-85160ABF5F45 Q38544598-CB14FE51-FD70-4641-A954-840A91307E5F Q38637663-2681FEE1-DA8B-42D4-8727-809708805A86 Q38646712-E47A31BA-8B2A-4F05-A800-8D199834F705 Q38729183-D4D93373-D8F4-4200-A692-7A933CA3767B Q38748979-33ED6E8D-8EC6-48D0-8B09-14D110920B30 Q38796753-84269C69-0EC7-4668-9336-28E1BD21F9AB Q38914168-92AE0D3E-F2FB-46C3-8CA2-C4FE90D9C089 Q39176380-C5CB45B9-F6B2-4531-B3D2-0E991D1EB7C8 Q39280954-2744E398-134A-4170-9935-BE0E320F4265 Q39393782-EA31FBFB-E240-4D14-98A2-5FD1AF12C6DA Q40088326-BB7A0189-6926-48FE-8081-8E8743E37CCD Q40222691-0DA2FD0A-4761-4A2E-A7A6-2B8BE785D8D6 Q40354436-C2EF5A0B-371D-46D5-ABFC-A076760F5BDA Q40537256-9EF97C6F-F29F-49F1-A91E-54070DC4B7FB Q40838379-74A3F269-35B1-458A-A10F-EAC5D4988C4A Q41925239-0EE7B534-5E24-4520-BFF4-FA05F23EB7D1 Q43373067-52BADC28-59FD-4415-B8A8-A87FB3AF517B Q47359574-50C9FF11-B7E4-4B20-9780-A4F13EAB139C Q47556747-4B8862A9-F419-4BFD-ABDC-A7D1D6B239DE Q47583783-5BCE70D5-2CCB-475C-B6EE-B6BBD3AB332C Q48505883-904DC951-A1BF-4A20-9871-8E236060E57A Q50170131-8894B023-13C6-40F4-AB49-E17C37F4B806 Q54943986-6887FA70-73EF-4185-B26C-EBFB02106282 Q55114845-FC100F38-50EF-4AC3-B8C2-385726363CCF Q57481193-C430B18B-BCF5-4D0C-B635-54C5CB479367

P2860

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

http://www.wikidata.org/entity/Q28246469

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@ast

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@en

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@nl

type

label

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@ast

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@en

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@nl

prefLabel

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@ast

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@en

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@nl

P1433

Q28246469-151094E6-6CFF-4AB0-85C5-99F013E51E76

P1476

Q28246469-907B6CB2-7091-4859-BDB4-D9B46FEF2661

P2093

Q28246469-0CDDE524-3BE1-4A3C-9D89-36E6DD0DBFA5

Q28246469-21330D30-50D9-4331-A4E9-5088D182C7C0

Q28246469-21C40983-58BD-4B6B-BEAD-00B2525A7222

Q28246469-383798C6-3CAA-4925-87D8-183B863C8936

Q28246469-5BDD0B15-1EF0-4D92-85E3-F0D6B1A31F7A

Q28246469-8CC0603E-B3D4-4D97-9201-6BCDCA8783FB

Q28246469-8CEDDD49-C7AD-4554-A5E6-252B53471F5E

Q28246469-B7A9F9DF-CC86-4285-922F-55B6F642BC96

Q28246469-C5D9CCFE-5AA4-437A-857F-23A86398B666

Q28246469-DD985D81-E752-4C8E-A37F-D4BF779BF9F7

P304

Q28246469-25D02355-D800-427F-887A-790AFB086AC1

P31

Q28246469-E634ADA8-F9FC-4E00-BCB5-12F7C3E7911D

P3181

Q28246469-29DC69F3-9475-4B8B-9B9E-F9FF4C36FFE2

P356

Q28246469-172F5A88-7B23-4EE1-9CFB-1929A67D68F5

P407

Q28246469-B4925E5C-4B68-4F8F-AF13-5C4AACCDDB45

P433

Q28246469-3B2C736C-FC0C-4ED3-87B8-C026B5F4C8FF

P478

Q28246469-680D8264-CB2B-424B-BFD7-E5694846B567

P50

Q28246469-8DF58893-3FF2-441C-87DA-EE25A10F2512

Q28246469-A7061FCE-2C6A-4F92-BB1D-45CE32E0550B

Q28246469-AFA2C04B-2EE9-4281-BA59-4213BC190A00

P577

Q28246469-C9C357C7-D3F4-4C0B-8AAD-37EA2C9844BF

P698

Q28246469-A1B01343-D085-49EF-B12D-CF5C0ADF997A

P921

Q28246469-8302B3BB-21B4-41E2-B97C-F2AEE6E90671

Q28246469-F117CA5A-78BC-4984-8174-E0A4903CDBD9

P3181

P356

SCIENCE.1255006

P1433

P1476

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

@en

P2093

Abhishek Kunwar

http://www.w3.org/2001/XMLSchema#string

Arani Chatterjee

http://www.w3.org/2001/XMLSchema#string

Ashutosh Agarwal

http://www.w3.org/2001/XMLSchema#string

Concepcion Estivariz

http://www.w3.org/2001/XMLSchema#string

Hamid Jafari

http://www.w3.org/2001/XMLSchema#string

Harish Verma

http://www.w3.org/2001/XMLSchema#string

Mohammad Ahmad

http://www.w3.org/2001/XMLSchema#string

Natalie A Molodecky

http://www.w3.org/2001/XMLSchema#string

R Bruce Aylward

http://www.w3.org/2001/XMLSchema#string

Rakesh Vishwakarma

http://www.w3.org/2001/XMLSchema#string

P304

922-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

241374

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1255006

http://www.w3.org/2001/XMLSchema#string

P407

P433

6199

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas C Grassly

Jagadish Deshpande

Mark A. Pallansch

P577

2014-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25146288

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases